Biotech Values

[CT]

That was dewophile's thesis, not mine. Mine was concern over lack of credibility RVNC has with investors/traders and the possible causes.

I do wish that they weren't spending money on PF trials. I'll be proven right or wrong in time, but why not choose only indications that Botox has had success in before moving on to new territory. Dysport was tried in PF without success and RVNC's 2a was unsuccessful IIRC.

Anyway, I'm long but always wondering if why I don't look like the smart money more often than not.